
Blood levels of active ingredients in sunscreens above a certain level should undergo toxicology testing, recommends the U.S. Food and Drug Administration.
Researchers from the FDA conducted a small randomized clinical trial of 24 healthy volunteers to determine bloodstream concentrations of four active ingredients (avobenzone, oxybenzone, octocrylene and ecamsule) in four sunscreens applied four times per day for four days with blood samples collected from study participants over seven days.
Read More..
Researchers report that all four active ingredients were found in blood samples at levels exceeding the threshold recommended for toxicology testing. The effect of these concentrations is unknown and further studies are needed to determine the clinical significance of these findings.
Researchers emphasize that their results don't suggest people refrain from using sunscreen, which prevents skin damage.
Source: Eurekalert
Advertisement
|
Recommended Reading
Latest Clinical Trials News




